UroMems, a biotechnology company based in Eybens, France, has secured $60.0M in new capital. The funding represents a significant infusion for the French firm, adding substantial financial resources to its operations.
The company, which operates as a biotechnology entity, is headquartered at 5, rue Raymond Chanas, 38320, Eybens, France. This latest capital raise further strengthens the financial position of the Eybens-based biotechnology company.













.png&w=3840&q=75)

